Gregory E. Cooper

990 total citations
23 papers, 736 citations indexed

About

Gregory E. Cooper is a scholar working on Psychiatry and Mental health, Molecular Biology and Neurology. According to data from OpenAlex, Gregory E. Cooper has authored 23 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 8 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Gregory E. Cooper's work include Dementia and Cognitive Impairment Research (10 papers), Alzheimer's disease research and treatments (4 papers) and CRISPR and Genetic Engineering (4 papers). Gregory E. Cooper is often cited by papers focused on Dementia and Cognitive Impairment Research (10 papers), Alzheimer's disease research and treatments (4 papers) and CRISPR and Genetic Engineering (4 papers). Gregory E. Cooper collaborates with scholars based in United States, United Kingdom and France. Gregory E. Cooper's co-authors include Gregory A. Jicha, Erin L. Abner, Charles D. Smith, Peter T. Nelson, Frederick A. Schmitt, Richard J. Kryscio, Linda J. Van Eldik, David W. Fardo, Lijie Wan and Mitchell S. Turker and has published in prestigious journals such as NeuroImage, Neurology and Neurobiology of Aging.

In The Last Decade

Gregory E. Cooper

23 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory E. Cooper United States 16 382 264 165 129 119 23 736
Magda Castellvı́ Spain 14 265 0.7× 226 0.9× 66 0.4× 103 0.8× 170 1.4× 23 590
H.-C. Liu Taiwan 9 205 0.5× 106 0.4× 199 1.2× 138 1.1× 52 0.4× 11 566
Etsuko Oshima Japan 15 276 0.7× 183 0.7× 102 0.6× 68 0.5× 114 1.0× 33 635
J.H. Jhoo South Korea 13 243 0.6× 128 0.5× 79 0.5× 53 0.4× 76 0.6× 22 531
D Masur United States 6 484 1.3× 494 1.9× 85 0.5× 127 1.0× 181 1.5× 7 961
Hyun Jeong Han South Korea 16 243 0.6× 211 0.8× 73 0.4× 56 0.4× 59 0.5× 51 595
Jorge J. Llibre‐Guerra United States 13 168 0.4× 201 0.8× 247 1.5× 157 1.2× 46 0.4× 51 834
Elisa de Paula França Resende Brazil 14 314 0.8× 260 1.0× 100 0.6× 54 0.4× 189 1.6× 31 669
Barbara Koumaras United States 14 222 0.6× 110 0.4× 132 0.8× 191 1.5× 242 2.0× 19 747
Fei Cao China 10 212 0.6× 145 0.5× 53 0.3× 85 0.7× 70 0.6× 21 636

Countries citing papers authored by Gregory E. Cooper

Since Specialization
Citations

This map shows the geographic impact of Gregory E. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory E. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory E. Cooper more than expected).

Fields of papers citing papers by Gregory E. Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory E. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory E. Cooper. The network helps show where Gregory E. Cooper may publish in the future.

Co-authorship network of co-authors of Gregory E. Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory E. Cooper. A scholar is included among the top collaborators of Gregory E. Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory E. Cooper. Gregory E. Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chilton, Paula M., Smita Ghare, B Charpentier, et al.. (2024). Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice. Gut Microbes. 16(1). 2389319–2389319. 11 indexed citations
2.
Shields, Lisa B. E., Susan Cooley, Gregory E. Cooper, et al.. (2024). Initial Experience with Lecanemab and Lessons Learned in 71 Patients in a Regional Medical Center. The Journal of Prevention of Alzheimer s Disease. 11(6). 1549–1562. 15 indexed citations
3.
Ghare, Smita, Hannah Gardener, José Gutierrez, et al.. (2023). Osteopontin Is Associated with Dementia in the Presence of Cerebral Small Vessel Disease. Cerebrovascular Diseases. 53(4). 495–500. 1 indexed citations
4.
Abner, Erin L., Peter T. Nelson, Gregory A. Jicha, et al.. (2019). Tobacco Smoking and Dementia in a Kentucky Cohort: A Competing Risk Analysis. Journal of Alzheimer s Disease. 68(2). 625–633. 10 indexed citations
5.
Kryscio, Richard J., Erin L. Abner, Gregory A. Jicha, et al.. (2015). SELF-REPORTED MEMORY COMPLAINTS: A COMPARISON OF DEMENTED AND UNIMPAIRED OUTCOMES. The Journal of Prevention of Alzheimer s Disease. 3(1). 1–7. 31 indexed citations
6.
Abner, Erin L., Peter T. Nelson, Frederick A. Schmitt, et al.. (2013). Self-Reported Head Injury and Risk of Late-Life Impairment and AD Pathology in an AD Center Cohort. Dementia and Geriatric Cognitive Disorders. 37(5-6). 294–306. 65 indexed citations
7.
Kryscio, Richard J., Erin L. Abner, Yushun Lin, et al.. (2013). Adjusting for Mortality when Identifying Risk Factors for Transitions to Mild Cognitive Impairment and Dementia. Journal of Alzheimer s Disease. 35(4). 823–832. 27 indexed citations
8.
Abner, Erin L., Richard J. Kryscio, Gregory E. Cooper, et al.. (2012). Mild Cognitive Impairment: Statistical Models of Transition Using Longitudinal Clinical Data. International Journal of Alzheimer s Disease. 2012. 1–9. 61 indexed citations
9.
Jicha, Gregory A., Erin L. Abner, Frederick A. Schmitt, et al.. (2011). Preclinical AD Workgroup staging: pathological correlates and potential challenges. Neurobiology of Aging. 33(3). 622.e1–622.e16. 51 indexed citations
10.
Riley, Kathryn, Gregory A. Jicha, Daron G. Davis, et al.. (2011). Prediction of Preclinical Alzheimer's Disease: Longitudinal Rates of Change in Cognition. Journal of Alzheimer s Disease. 25(4). 707–717. 36 indexed citations
11.
Jicha, Gregory A., F.A. Schmitt, Erin L. Abner, et al.. (2008). Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiology of Aging. 31(10). 1805–1813. 88 indexed citations
12.
Jicha, Gregory A., Erin L. Abner, Frederick A. Schmitt, et al.. (2008). Clinical Features of Mild Cognitive Impairment Differ in the Research and Tertiary Clinic Settings. Dementia and Geriatric Cognitive Disorders. 26(2). 187–192. 28 indexed citations
13.
Grabowski, Thomas J., Hanna Damásio, Daniel Tranel, et al.. (2003). Residual naming after damage to the left temporal pole: a PET activation study. NeuroImage. 19(3). 846–860. 25 indexed citations
14.
Greenberg, Steven M., Youngah Shin, Thomas J. Grabowski, et al.. (2003). Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation. Neurology. 60(6). 1020–1022. 43 indexed citations
15.
Turker, Mitchell S., Padmaja Mummaneni, & Gregory E. Cooper. (1995). The Mouse APRT Gene as a Model for Studying Epigenetic Gene Inactivation. Advances in experimental medicine and biology. 370. 647–652. 2 indexed citations
16.
Cooper, Gregory E., et al.. (1993). Hemidemethylation is sufficient for chromatin relaxation and transcriptional activation of methylatedaprt gene in mouse P19 embryonal carcinoma cell line. Somatic Cell and Molecular Genetics. 19(3). 221–229. 12 indexed citations
17.
18.
19.
Cooper, Gregory E., et al.. (1992). At least two distinct epigenetic mechanisms are correlated with high-frequency ?switching? for aprt phenotypic expression in mouse embryonal carcinoma stem cells. Somatic Cell and Molecular Genetics. 18(3). 215–225. 18 indexed citations
20.
Cooper, Gregory E., et al.. (1991). Molecular analysis of APRT deficiency in mouse P19 teratocarcinoma stem cell line. Somatic Cell and Molecular Genetics. 17(2). 105–116. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magda Castellvı́ Breakdown of academic impact, for papers by H.-C. Liu Breakdown of academic impact, for papers by Etsuko Oshima Breakdown of academic impact, for papers by J.H. Jhoo Breakdown of academic impact, for papers by D Masur Breakdown of academic impact, for papers by Hyun Jeong Han Breakdown of academic impact, for papers by Jorge J. Llibre‐Guerra Breakdown of academic impact, for papers by Elisa de Paula França Resende Breakdown of academic impact, for papers by Barbara Koumaras Breakdown of academic impact, for papers by Fei Cao
Rankless by CCL
2026